The Drug Eluting Stents Center

Filter Your Results




Two-Year Data Presented From BIOLUX P-III Registry of Biotronik's Passeo-18 Lux DCB

April 18, 2019 -- Biotronik announced that 2-year data from the BIOLUX P-III all-comers registry of the company's Passeo-18 Lux drug-coated balloon (DCB) were presented at…

Enrollment Resumes in the TRANSCEND Trial of Surmodics' SurVeil Paclitaxel-Coated Balloon

April 17, 2019 -- Surmodics, Inc. announced that it has resumed patient enrollment for the TRANSCEND clinical trial and has completed approximately 75% of its goal of enrollin…

IMPERIAL Subanalyses Support Boston Scientific's Eluvia Stent in Calcified Lesions and CTOs

April 16, 2019 -- Boston Scientific Corporation announced that results from subanalyses of the IMPERIAL clinical trial for the company's Eluvia drug-eluting vascular stent…

CIRSE Position Statement Addresses the Use of Paclitaxel-Coated Devices in PAD

April 12, 2019 -- The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) announced an updated CIRSE Position Statement on the use of paclitaxel-coated ba…

Cook Medical Letter to Physicians Addresses Paclitaxel Data

March 26, 2019 -- In a letter to physicians, Cook Medical communicated the company's latest information and insights regarding concerns about long-term safety of paclitaxe…

BD Issues Statement in Response to FDA’s Letter Announcing Long-Term Data Review of Paclitaxel Devices Used in PAD

March 22, 2019 -- BD (Becton, Dickinson and Company) has issued a statement regarding the recent FDA letter that announced the preliminary review of long-term data on the use …

Highlights From the VIVA Vascular Leaders Forum on Paclitaxel Safety

March 2019—Points of consensus, contention, and paths forward.

FDA to Convene Advisory Committee Meeting After Preliminary Review Finds Signal of Increased Mortality With Paclitaxel-Eluting Devices

March 15, 2019 -- The FDA has announced that its preliminary review of the long-term follow-up data on paclitaxel-coated balloons and paclitaxel-eluting stents to treat periph…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.